Madrigal Pharmaceuticals shares are trading higher after HC Wainwright & Co. raised its price target on the stock from $275 to $405.
Portfolio Pulse from Benzinga Newsdesk
Madrigal Pharmaceuticals' stock price increased following an upgrade in its price target from $275 to $405 by HC Wainwright & Co.
March 12, 2024 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Madrigal Pharmaceuticals' stock price is likely to experience a short-term increase following the raised price target by HC Wainwright & Co.
The upgrade in the price target by a reputable financial institution like HC Wainwright & Co. typically signals a strong belief in the company's future performance. This can lead to increased investor confidence and a rise in stock price, especially in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100